ClinConnect ClinConnect Logo
Search / Trial NCT05829421

Addressing Problems in Managing Daily Tasks Due to Poststroke Cognitive Impairments

Launched by EMMA GHAZIANI · Apr 24, 2023

Trial Information

Current as of August 19, 2025

Recruiting

Keywords

Occupational Therapy Neuropsychology Stroke Rehabilitation Cognitive Rehabilitation Activities Of Daily Living (Adl)

ClinConnect Summary

This clinical trial is looking into how to help people who have had a stroke manage everyday tasks better when they experience mild to moderate cognitive impairments. Cognitive impairments can make it hard for someone to think clearly or remember things, which can affect their ability to perform daily activities, like cooking or managing finances. The study aims to figure out how to create effective support and rehabilitation programs for these individuals, focusing on their specific needs and challenges.

To be eligible for this trial, participants must be at least 18 years old, have experienced their first stroke, and live independently before the stroke. They should also still have some difficulties with daily tasks due to cognitive issues after being discharged from the hospital. Caregivers can join the trial if they are closely involved with the patient and can give their consent. Participants can expect to engage in tailored rehabilitation activities designed to improve their daily functioning and cognitive skills. This study is currently recruiting participants in Frederiksberg Municipality, Denmark, and aims to better understand how to support stroke survivors in their daily lives.

Gender

ALL

Eligibility criteria

  • PATIENTS:
  • Inclusion criteria:
  • first-ever symptomatic stroke,
  • age ≥ 18 years,
  • residence in Frederiksberg Municipality, Denmark,
  • independent in pre-stroke everyday life (≤ 2 points on the modified Rankin Scale, mRS),
  • experiencing problems in performing ADLs due to cognitive impairment; these problems are expected to still be present at hospital discharge,
  • medical condition allows commencement of rehabilitation focused on ADL and cognition
  • fully aware or mild-to-moderate unawareness of deficits (≤ 2 points on the Bisiach Anosognosia Scale, BAS),
  • a global cognitive function corresponding to ≥ 17 points on the Montreal Cognitive Assessment, MoCA,
  • ≤ 10 points on the depression subscale of the Hospital Anxiety and Depression Scale, HADS,
  • able to provide informed consent, as evaluated by the recruiting healthcare professional(s),
  • logistically possible to perform baseline assessments and create an individualised intervention plan during hospital stay
  • provides informed consent
  • Exclusion criteria:
  • psychiatric conditions causing difficulties or preventing participation, as evaluated by the recruiting health care professional(s)
  • communication problems causing difficulties or preventing participation, as evaluated by the recruiting healthcare professional(s)
  • CAREGIVERS:
  • Inclusion criteria:
  • appointed as close carer (by a patient who consented to participate),
  • age ≥18y,
  • provides informed consent.
  • Exclusion criteria:
  • -communication problems or other issues causing difficulties in participation as evaluated by the recruiting healthcare professional(s).
  • Patients without a close carer will not be excluded.
  • CLINICAL STAFF:
  • Inclusion criteria:
  • appointed as local project managers, or OTs or NPs who conduct assessments or deliver the intervention in the participating centres,
  • provides informed consent.
  • Exclusion criteria:
  • - unable to to follow a preliminary English version of the intervention manual.

About Emma Ghaziani

Emma Ghaziani is a dedicated clinical trial sponsor with a strong commitment to advancing medical research and improving patient outcomes. With a focus on innovative therapies and methodologies, Ghaziani leads the development and management of clinical trials that adhere to the highest ethical and regulatory standards. Her expertise spans various therapeutic areas, ensuring that each trial not only meets rigorous scientific criteria but also prioritizes participant safety and well-being. By fostering collaboration among researchers, healthcare professionals, and stakeholders, Emma Ghaziani plays a pivotal role in the translation of groundbreaking discoveries into effective treatment options.

Locations

Copenhagen, , Denmark

Frederiksberg, , Denmark

Frederiksberg, , Denmark

Frederiksberg, , Denmark

Patients applied

0 patients applied

Trial Officials

Hanne Christensen, Professor

Principal Investigator

Bispebjerg and Frederiksberg Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported